Hypercalcemia and overexpression of CYP27B1 in a patient with nephrogenic systemic fibrosis: Clinical vignette and literature review

Journal of Bone and Mineral Research

Volumn 24, Issue 6, 2009, Pages 1135-1139

  Pao, Vivian Y ^a   Chang, Sandra ^a   Shoback, Dolores M ^a   Bikle, Daniel D ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

CYP27B1; End stage renal disease; Hypercalcemia; Nephrogenic systemic fibrosis

Indexed keywords

CALCIDIOL 1 MONOOXYGENASE; ETRETIN; GADOLINIUM; OXYCODONE; PAMIDRONIC ACID; PREDNISONE; QUETIAPINE; SERTRALINE; SEVELAMER; TRAZODONE;

AGED; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; HEMODIALYSIS; HUMAN; HUMAN TISSUE; HYPERCALCEMIA; LABORATORY TEST; MALE; NEPHROGENIC SYSTEMIC FIBROSIS; PHYSICAL EXAMINATION; PROTEIN EXPRESSION; SKIN BIOPSY;

25-HYDROXYVITAMIN D3 1-ALPHA-HYDROXYLASE; AGED; DIPHOSPHONATES; HUMANS; HYPERCALCEMIA; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MALE; NEPHROGENIC FIBROSING DERMOPATHY; RENAL DIALYSIS;

EID: 66349102519     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.081261     Document Type: Article

References (21)

1. Cowper S, Robin H, Steinberg S, Su L, Gupta S, LeBoit P 2000 Scleromyxoedema-like cutaneous diseases in renal-dialysis patients. Lancet 356:1000-1001.
2. Ting W, Stone M, Madison K, Kurtz K 2003 Nephrogenic fibrosing dermopathy with systemic involvement. Arch Dermatol 139:903-906. (Pubitemid 36898926)
3. Grobner T 2006 Gadolinium - a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis? Nephrol Dial Transplant 21:1104-1108.
4. Xie Z, Munson S, Huang N, Portale A, Miller W, Bikle D 2002 The mechanism of 1,25-dihydroxyvitamin D(3) auto-regulation in keratinocytes. J Biol Chem 277:36987-36990.
5. Sandler L, Winearls C, Fraher L, Clemens T, Smith R, O'Riordan J 1984 Studies of the hypercalcaemia of sarcoidosis: Effect of steroids and exogenous vitamin D3 on the circulating concentrations of 1,25-dihydroxy vitamin D3. QJM 53:165-180. (Pubitemid 14044801)
6. Carre M, Ayigbede O, Miravet L, Rasmussen H 1974 The effect of Prednisolone upon the metabolism and action of 25-hydroxy-and 1,25-dihydroxyvitamin D3. Proc Natl Acad Sci USA 71:2996-3000.
7. Swartz R, Crofford L, Phan S, Ike R, Su L 2003 Nephrogenic fibrosing dermopathy: A novel cutaneous fibrosing disorder in patients with renal failure. Am J Med 114:563-572. (Pubitemid 36577259)
8. Gibson S, Farver C, Prayson R 2006 Multiorgan involvement in nephrogenic fibrosing dermopathy: An autopsy case and review of the literature. Arch Pathol Lab Med 130:209-212. (Pubitemid 43237993)
9. Center for Disease Control and Prevention 2007 Nephrogenic fibrosing dermopathy associated with exposure to gadolinium-containing contrast agents-St. Louis, Missouri, 2002-2006. MMWR Morb Mortal Wkly Rep 56:137-141.
10. Perazella M 2008 Tissue deposition of gadolinium and development of NSF: A convergence of factors. Semin Dial 21:150-154.
11. Swan S, Lambrecht L, Townsend R, Davies B, McCloud S, Parker J, Bensel K, LaFrance N 1999 Safety and pharmacokinetic profile of gadobenate dimeglumine in subjects with renal impairment. Invest Radiol 34:443-448. (Pubitemid 29302836)
12. Cowper S, Rabach M, Girardi M 2008 Clinical and histological findings in nephrogenic systemic fibrosis. Eur J Radiol 66:191-199.
13. Todd DJKA, Chibnik LB, Kay J 2007 Cutaneous changes of nephrogenic systemic fibrosis: Predictor of early mortality and association with gadolinium exposure. Arthrit Rheum 56:3433-3441. (Pubitemid 47585439)
14. Zehnder D, Bland R, Williams M, McNinch R, Howie A, Stewart P, Hewison M 2001 Extrarenal expression of 25-hydroxyvitamin d(3)-1 alpha-hydroxylase. J Clin Endocrinol Metab 86:888-894.
15. Bikle D, Nemanic M, Whitney J, Elias P 1986 Neonatal human foreskin keratinocytes produce 1,25-dihydroxyvitamin D3. Biochemistry 25:1545-1548. (Pubitemid 16013928)
16. Bikle D, Pillai S, Gee E, Hincenbergs M 1991 Tumor necrosis factor-alpha regulation of 1,25-dihydroxyvitamin D production by human keratinocytes. Endocrinology 129:33-38.
17. Bikle D, Pillai S, Gee E, Hincenbergs M 1989 Regulation of 1,25-dihydroxyvitamin D production in human keratinocytes by interferon-gamma. Endocrinology 124:655-660. (Pubitemid 19057051)
18. Karakelides H, Geller J, Schroeter A, Chen H, Behn P, Adams J, Hewison M, Wermers R 2006 Vitamin D-mediated hypercalcemia in slack skin disease: Evidence for involvement of extrarenal 25-hydroxyvitamin D lalpha-hydroxylase. J Bone Miner Res 21:1496-1499. (Pubitemid 44300057)
19. Introcaso C, Hivnor C, Cowper S, Werth V 2007 Nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis: A case series of nine patients and review of the literature. Int J Dermatol 46:447-452. (Pubitemid 46711420)
20. Cowper S, Bucala R, LeBoit P 2006 Nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis-setting the record straight. Semin Arthritis Rheum 35:208-210. (Pubitemid 43185212)
21. Edward M, Quinn J, Mukherjee S, Jensen M, Jardine A, Mark P, Burden A 2008 Gadodiamide contrast agent 'activates' fibroblasts: A possible cause of nephrogenic systemic fibrosis. J Pathol 214:584-593.